For the year ending 2025-12-31, FHTX has $198,103K in assets. $306,603K in debts. $80,876K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 80,876 | |||
| Marketable securities | 78,018 | |||
| Restricted cash | 1,250 | |||
| Prepaid expenses and other current assets | 3,091 | |||
| Total current assets | 163,235 | |||
| Property and equipment, net | 1,915 | |||
| Restricted cash | 2,000 | |||
| Other assets | 4 | |||
| Operating lease right-of-use assets | 30,949 | |||
| Total assets | 198,103 | |||
| Accounts payable | 4,266 | |||
| Accrued expenses and other current liabilities | 11,357 | |||
| Operating lease liabilities | 923 | |||
| Deferred revenue | 43,192 | |||
| Total current liabilities | 59,738 | |||
| Operating lease liabilities, net of current portion | 40,347 | |||
| Deferred revenue, net of current portion | 205,962 | |||
| Other liabilities | 556 | |||
| Total liabilities | 306,603 | |||
| Common stock, 0.0001 par value 175,000,000 shares authorized at december31, 2025 and 2024 56,657,329 shares issued and outstanding at december31, 2025 and 55,594,131 shares issued and outstanding at december31, 2024 | 6 | |||
| Additional paid-in capital | 523,937 | |||
| Accumulated other comprehensive gain | 24 | |||
| Accumulated deficit | -632,467 | |||
| Total stockholders deficit | -108,500 | |||
| Total liabilities and stockholders deficit | 198,103 | |||
Foghorn Therapeutics Inc. (FHTX)
Foghorn Therapeutics Inc. (FHTX)